DM Goldenberg - The American journal of medicine, 1993 - Elsevier Anticancer antibodies have had a long history in the management of cancer, with
major applications having been shown in the immunohistochemistry and immunoassay
of tumor-associated antigen markers. With the advent of hybridomaderived ... Cited by 143 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] HA Lehr, M Leunig, MD Menger, D Nolte, K … - The American journal of pathology, 1993 - pubmedcentral.nih.gov For many years, observation chambers, im- planted in various animal species and
in man, have been usedfor intravital microscopy of the microcirculation in
granulation tissue, pre- formed tissue,or of the microvascularization of ... Cited by 140 - Related articles - BL Direct - All 4 versions
A Todorovska, RC Roovers, O Dolezal, AA … - Journal of immunological methods, 2001 - Elsevier Multivalent recombinant antibody fragments provide high binding avidity and
unique specificity to a wide range of target antigens and haptens. This review
describes the design and expression of diabodies, triabodies and ... Cited by 139 - Related articles - All 6 versions
BS Coller, LE Scudder, J Beer, HK Gold, JD … - Ann NY Acad Sci, 1991 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 145 - Related articles - All 4 versions
- ►aacrjournals.org [PDF] LM Weiner, JI Clark, M Davey, WS Li, IG de … - Cancer Research, 1995 - AACR Since the introduction of monoclonal antibody technology, a van ety of such
antibodies has been used in clinical trials with the intent of inducing
inflammation at tumor sites by recruitment of cytotoxic effector cells, ... Cited by 99 - Related articles - BL Direct - All 4 versions
RO Dillman - Journal of clinical oncology, 2002 - jcojournal.org NON-HODGKIN'S LYMPHOMA is the only invasive malignancy that continued to
increase in both frequency and death rate during the last decade of the 20th
century. In 2001, it was estimated that non-Hodgkin's lymphomas would ... Cited by 96 - Related articles - BL Direct - All 6 versions
AA Kortt, O Dolezal, BE Power, PJ Hudson - Biomolecular Engineering, 2001 - Elsevier Recombinant antibody fragments can be engineered to assemble into stable
multimeric oligomers of high binding avidity and specificity to a wide range of
target antigens and haptens. This review describes the design and ... Cited by 91 - Related articles - All 5 versions
SJ Knox, RF Meredith - Seminars in Radiation Oncology, 2000 - Elsevier Radioimmunotherapy (RIT) is a promising new therapy for the treatment of a
variety of malignancies. General principles of RIT are discussed, including
important considerations in the selection of monoclonal antibodies (MAb) ... Cited by 69 - Related articles - BL Direct - All 4 versions
- ►aacrjournals.org [PDF] TR Shockley, K Lin, C Sung, JA Nagy, RG … - Cancer Research, 1992 - AACR Department of Chemical Engineering, Massachusetts Institute of Technology.
Cambridge, Massachusetts 02139 ¡TKSJ; Departments of Pathology, Beth Israel
Hospital and Harvard Medical School, and the Charles A. Dana Research ... Cited by 62 - Related articles - All 3 versions
